Tag: Stem cells
Houston Stem Cells Clinic Inc Opened By China Infrastructure Construction Corp
China Infrastructure Construction Corp., (CHNC) has announced that it has opened Houston Stem Cells Clinic Inc., as a wholly owned subsidiary of CHNC.
According to...
Cellect Prepared For US Clinical Trial
Cellect Biotechnology Ltd. has announced a collaboration with Washington University in St. Louis, Missouri, USA, in a U.S. Phase I/II study aimed at determining...
Cellect Biotechnology Completes Scale-Up Of Clinical Grade FasL; Enabling Stem Cell Therapy
Cellect Biotechnology Ltd. has announced that it has concluded the scale-up development and manufacturing of clinical grade FasL in collaboration with its outsourced supplier.
Founded...
StemCyte Receives IND Clearance Of Mononuclear Stem Cells In Spinal Cord Injury Clinical Trials
On December 14, 2018, the U.S. Food and Drug Administration
(FDA), approved StemCyte’s Phase II Investigational New Drug (IND) application
for Allogeneic Human Leukocyte Antigen (HLA)-Matched...
FDA Calls Out Companies Marketing Stem Cell Products Without BLA Approval
The U.S. Food and Drug Administration has warned Genetech,
Inc. of San Diego, California and its president, Edwin N. Pinos for marketing
stem cell products without...
Phase I/II Study Of Gamida Cell’s NiCord® Universal Bone Marrow Transplant Solution Published
Gamida Cell Ltd., a leading cellular and immune therapeutics company, has announced the publication of data from a multi-center Phase 1/2 clinical study evaluating...
Cevitr Serves Robotic Process Automation To ReeLabs Stem Cell Bank And Healthcare Provider
Cevitr, has automated business processes for their client ReeLabs. ReeLabs was able to adopt Robotic Process Automation (RPA) technology by taking advantage of Cevitr's...
FDA Clearance For Cesca Therapeutics’ Automated Cord Blood Stem Cell Collection Solution
Cesca Therapeutics Inc., has announced that its device subsidiary, ThermoGenesis® Corp., has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for...
Orgenesis And Hemogenyx Collaborate To Manufacture Hu-PHEC Regenerative Technology
Orgenesis Inc. and Hemogenyx Pharmaceuticals PLC. are collaborating to develop and commercialize Hemogenyx’s Human Postnatal Hemogenic Endothelial (Hu-PHEC) technology.
Founded in 2008, headquartered in Germantown,...
Meadowlands Veterinary Hospital Introduces Cutting Edge Regenerative Medicine Techniques
Meadowlands Veterinary Hospital was established in 2017 to provide exceptional veterinary medical care to pets, and their owners, in Hackensack, New Jersey, and the...



















